{"id":"W2110991424","doi":"10.1016/j.juro.2012.10.017","title":"Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":368,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Astellas Pharma","keywords":"Mirabegron; Overactive bladder; Medicine; Placebo; Adverse effect; Urology; Urination; Randomized controlled trial; Urinary incontinence; Urinary system; Internal medicine; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002645536,0.001379361,0.002622508,0.0002805451,0.0003965356,0.001002013,0.0005768415,0.00140064,0.005475874],"category_scores_gemma":[0.003197301,0.0005609125,0.002003933,0.0003472018,0.0009339711,0.000814832,0.0003229032,0.002998339,0.0008903853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005811515,"about_ca_system_score_gemma":0.0015423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006305168,"about_ca_topic_score_gemma":0.001875777,"domain_scores_codex":[0.9989536,0.0006584057,0.00007704957,0.0001273658,0.00008664527,0.00009691351],"domain_scores_gemma":[0.9984437,0.0005124396,0.0003914361,0.0001172697,0.0001245209,0.0004106905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.968884,0.006724396,0.0007814903,0.000684691,0.001503324,0.00004270517,0.00005479019,0.0002775527,0.002467559,0.00007381114,0.001167527,0.01733824],"study_design_scores_gemma":[0.9502578,0.04682326,0.001604171,0.00003081788,0.0004351219,0.00002368003,0.00001152715,0.0001196016,0.0001870293,0.00005775291,0.0004424939,0.000006739823],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9611367,0.01703231,0.001407024,0.002804112,0.001281935,0.009461827,0.002390692,0.0002208266,0.004264548],"genre_scores_gemma":[0.9788006,0.005437399,0.00224072,0.002174352,0.0004696306,0.00622429,0.00188612,0.00002746044,0.002739452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005475874,"threshold_uncertainty_score":0.01831865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02180478165129066,"score_gpt":0.3304379304377846,"score_spread":0.3086331487864939,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}